IVA Stock Summary and Trading Ideas (Inventiva S.A. - American Depository Shares | NASDAQ:IVA)

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Inventiva S.A. - American Depository Shares trades on the NASDAQ stock market under the symbol IVA.

As of September 14, 2026, IVA stock price declined to $3.96 with 957,187 million shares trading.

IVA has a beta of 1.74, meaning it tends to be more sensitive to market movements. IVA has a correlation of 0.07 to the broad based SPY ETF.

IVA has a market cap of $935.43 million. This is considered a Small Cap stock.

Last quarter Inventiva S.A. - American Depository Shares reported $5 million in Revenue and -$2.14 earnings per share. This fell short of revenue expectation by $-936,000 and missed earnings estimates by -$.48.

In the last 3 years, IVA traded as high as $7.98 and as low as $1.53.

The top ETF exchange traded funds that IVA belongs to (by Net Assets): MEDI, APIE.

IVA has underperformed the market in the last year with a price return of -31.4% while the SPY ETF gained +17.1%. However, in the short term, IVA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.2% vs +3.6% return in SPY. But in the last 2 weeks, IVA shares have been beat by the market, returning -15.8% compared to an SPY return of -0.9%.

IVA support price is $3.87 and resistance is $4.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVA shares will trade within this expected range on the day.